skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:054988/0114   Pages: 8
Recorded: 01/21/2021
Attorney Dkt #:1380_1449
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 25
1
Patent #:
8067547
Issue Dt:
11/29/2011
Application #:
11916793
Filing Dt:
05/27/2008
Publication #:
US20090263382
Pub Dt:
10/22/2009
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
2
Patent #:
8399624
Issue Dt:
03/19/2013
Application #:
12823488
Filing Dt:
06/25/2010
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
3
Patent #:
8399625
Issue Dt:
03/19/2013
Application #:
12823551
Filing Dt:
06/25/2010
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
4
Patent #:
8389693
Issue Dt:
03/05/2013
Application #:
13245420
Filing Dt:
09/26/2011
Publication #:
US20120064077
Pub Dt:
03/15/2012
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
5
Patent #:
8691228
Issue Dt:
04/08/2014
Application #:
13708500
Filing Dt:
12/07/2012
Publication #:
US20130171143
Pub Dt:
07/04/2013
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
6
Patent #:
9005924
Issue Dt:
04/14/2015
Application #:
13765302
Filing Dt:
02/12/2013
Publication #:
US20130165639
Pub Dt:
06/27/2013
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
7
Patent #:
9051366
Issue Dt:
06/09/2015
Application #:
13765326
Filing Dt:
02/12/2013
Publication #:
US20130165640
Pub Dt:
06/27/2013
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
8
Patent #:
9404930
Issue Dt:
08/02/2016
Application #:
14072165
Filing Dt:
11/05/2013
Publication #:
US20140134183
Pub Dt:
05/15/2014
Title:
ANTIBODY TO HUMAN IL-1 BETA
9
Patent #:
9315572
Issue Dt:
04/19/2016
Application #:
14185783
Filing Dt:
02/20/2014
Publication #:
US20140171634
Pub Dt:
06/19/2014
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
10
Patent #:
9409979
Issue Dt:
08/09/2016
Application #:
14644441
Filing Dt:
03/11/2015
Publication #:
US20150232543
Pub Dt:
08/20/2015
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
11
Patent #:
9403903
Issue Dt:
08/02/2016
Application #:
14706484
Filing Dt:
05/07/2015
Publication #:
US20150315294
Pub Dt:
11/05/2015
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
12
Patent #:
9914772
Issue Dt:
03/13/2018
Application #:
14740434
Filing Dt:
06/16/2015
Publication #:
US20160194392
Pub Dt:
07/07/2016
Title:
ANTIBODIES AGAINST IL-1 BETA
13
Patent #:
9683034
Issue Dt:
06/20/2017
Application #:
15064067
Filing Dt:
03/08/2016
Publication #:
US20160185850
Pub Dt:
06/30/2016
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
14
Patent #:
10233238
Issue Dt:
03/19/2019
Application #:
15127976
Filing Dt:
09/21/2016
Publication #:
US20170107282
Pub Dt:
04/20/2017
Title:
TNF ALPHA ANTIBODY OR FRAGMENT THEREOF AND METHODS OF USE
15
Patent #:
9994645
Issue Dt:
06/12/2018
Application #:
15193432
Filing Dt:
06/27/2016
Publication #:
US20160347864
Pub Dt:
12/01/2016
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
16
Patent #:
NONE
Issue Dt:
Application #:
15195411
Filing Dt:
06/28/2016
Publication #:
US20160304627
Pub Dt:
10/20/2016
Title:
ACCEPTOR FRAMEWORK FOR CDR GRAFTING
17
Patent #:
10077302
Issue Dt:
09/18/2018
Application #:
15202982
Filing Dt:
07/06/2016
Publication #:
US20170051054
Pub Dt:
02/23/2017
Title:
METHOD OF INHIBITING HUMAN IL-1 BETA BY ADMINISTERING AN ANTIBODY TO HUMAN IL-1 BETA
18
Patent #:
NONE
Issue Dt:
Application #:
15896309
Filing Dt:
02/14/2018
Publication #:
US20180258165
Pub Dt:
09/13/2018
Title:
ANTIBODIES AGAINST IL-1 BETA
19
Patent #:
NONE
Issue Dt:
Application #:
16079202
Filing Dt:
08/23/2018
Publication #:
US20190048085
Pub Dt:
02/14/2019
Title:
MODIFIED CELLS FOR IMMUNOTHERAPY
20
Patent #:
NONE
Issue Dt:
Application #:
16079202
Filing Dt:
08/23/2018
Publication #:
US20190048085
Pub Dt:
02/14/2019
PCT #:
US2017019301
Title:
MODIFIED CELLS FOR IMMUNOTHERAPY
21
Patent #:
11434294
Issue Dt:
09/06/2022
Application #:
16079210
Filing Dt:
08/23/2018
Publication #:
US20190055312
Pub Dt:
02/21/2019
Title:
BINDING MEMBERS TO PD-L1
22
Patent #:
10626171
Issue Dt:
04/21/2020
Application #:
16118124
Filing Dt:
08/30/2018
Publication #:
US20180362642
Pub Dt:
12/20/2018
Title:
NUCLEIC ACID ENCODING ANTIBODY TO HUMAN IL-1 BETA
23
Patent #:
10995138
Issue Dt:
05/04/2021
Application #:
16258886
Filing Dt:
01/28/2019
Publication #:
US20190144532
Pub Dt:
05/16/2019
Title:
NUCLEIC ACIDS ENCODING BINDING MEMBERS TO TNF ALPHA
24
Patent #:
11267884
Issue Dt:
03/08/2022
Application #:
16822952
Filing Dt:
03/18/2020
Publication #:
US20200239565
Pub Dt:
07/30/2020
Title:
ANTIBODY TO HUMAN IL-1 BETA
25
Patent #:
NONE
Issue Dt:
Application #:
16879978
Filing Dt:
05/21/2020
Publication #:
US20200362059
Pub Dt:
11/19/2020
Title:
Acceptor Framework for CDR Grafting
Assignor
1
CELL MEDICA SWITZERLAND AG
Exec Dt:
12/22/2020
Assignee
1
CELL MEDICA INC.
2617 BISSONNET ST
SUITE 300
HOUSTON, TEXAS 77005
Correspondence name and address
MYERS BIGEL, P.A.
P.O. BOX 37428
RALEIGH, NC 27627

Search Results as of: 06/25/2025 08:34 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT